Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

NCT02229240 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was cancelled prior to enrolling any patients

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Albiglutide
DRUG: Matching albiglutide placebo

Sponsor

GlaxoSmithKline

Collaborators

[object Object]